(Q44183110)
Statements
ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy (English)
Alan E Wakeling
Simon P Guy
Jim R Woodburn
Susan E Ashton
Brenda J Curry
Andrew J Barker